Concepedia

Ingemar Starke

IS

6

Publications

189

Citations

6

H-Index

1989

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Ingemar Starke is an author at AstraZeneca (Sweden) specializing in organic chemistry, gastroenterology, and chemistry.

ORCID

Top concepts

Publications per year

1989–2023

6

Publications

6

A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain

Alexandra E. Conibear, Junaid Asghar, R. W. Hill et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 60 citations · Full text

Discovery of AZD2716: A Novel Secreted Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Inhibitor for the Treatment of Coronary Artery Disease

Fabrizio Giordanetto, Daniel Pettersen, Ingemar Starke et al. · ACS Medicinal Chemistry Letters · 2016 · 40 citations · Full text

A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans

Francisco J. Caballero‐Camino, Pedro M. Rodrigues, Fredrik Wångsell et al. · Hepatology · 2023 · 35 citations · Full text

S1301 The IBAT Inhibition by A3309 – A Potential Mechanism for the Treatment of Constipation

Per‐Göran Gillberg, Mikael Dahlström, Ingemar Starke et al. · Gastroenterology · 2010 · 25 citations

, , +6

Synthesis of a new sulfur-containing dipeptide analogue

J. Olle Karlsson, Anita Lundblad, Bengt Malm et al. · Tetrahedron Letters · 1989 · 17 citations

, ,

Rows per page

1–5 of 6